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ABSTRACT Dermorphin, a natural peptide opioid containing a D-Ala2 residue, has been studied in dimethyl sulfoxide
(DMSO) solution by means of several one-dimensional and two-dimensional 'H nuclear magnetic resonance (NMR)
methods at various fields from 80 to 600 MHz. The combined use of conventional NMR parameters and of nuclear
Overhauser effect effects points to an essentially extended structure. This conformation may be, in part, the result of
strong interaction of the amide groups with DMSO molecules.
INTRODUCTION
Since the discovery of the enkephalins in 1975 (1), many
different endogenous peptides with opioid properties have
been found in living organisms. These compounds interact
with several different receptor sites (,u, 6, X, and a) (2) and
are often many times more active than morphine and other
exogenous opioids. Moreover, in spite of the serious diffi-
culty posed by their conformational flexibility in the study
of substrate-receptor interactions, they can be quite a
useful source of complementary information with respect
to their alkaloid counterparts. In 1981 a heptapeptide
opioid, dermorphin (Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-
NH2), was isolated from the skin of South American frogs
(3, 4). Its preferential receptor site is the j site, like
morphine, but its activity is by far much higher, -2,000
times more than morphine. The presence of a D-amino
acid, quite unusual for a biological substance of nonbacter-
ial origin, seems to be fundamental for its activity because
its L-Ala2 analogue is virtually devoid of analgesic activity
(5). Here we wish to extend our preliminary studies (6, 7)
with a major emphasis on the dynamic behavior in solution
of DMSO. In fact, although this medium is far from the
likely biological environment in which the substrate-recep-
tor interaction takes place, it is one of the best solvents for a
preliminary delimitation of the conformational space and
its flexibility in it. Therefore this paper moves in two
different but complementary directions: (a) a comparison
between dermorphin and its less active, synthetic, L-
analogue; (b) a careful study of the conformation in
solution of the former.
METHODS
The hydrochloride salt of dermorphin and the trifluoroacetic salt of its
L-analogue were prepared by conventional methods in solution as
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previously described (8). All solutions were obtained by dissolving the
appropriate amount in -0.500 ml of dimethyl sulfoxide (DMSO-d6).
Concentrations -10 mM and 0.300 ml of solution were used for nuclear
magnetic resonance (NMR) measurements in a 5 mm OD tube. NMR
spectra were recorded at different fields on a 200 Nicolet spectrometer
(Nicolet Instrument Corp., Madison, WI), on 80, 270, 400, and 500
Bruker spectrometer (Bruker Instruments, Inc., Billerica, MA) and on a
600 MHz homebuilt spectrometer of the Carnegie-Mellon Institute
(Pittsburgh, PA). The use of different higher fields was suggested from
considerable overlap of peaks. Moreover, as previously described (9) on
the dodecapeptide valinomycin for molecules of appropriate size, dipolar
and scalar mechanisms may be distinguished by the frequency depen-
dence of the nuclear Overhauser effect (NOE). All peaks were referred to
the DMSO resonance arbitrarily located at 2.5 ppm and all spectra were
run at a temperature of 2980K. For one-dimensional experiments 16 or 32
K data points were used for acquisition and 32 or 64 K, respectively, for
transformation. NOE difference spectra were determined by applying a
1.5-s low-power saturating pulse at appropriate peak position, followed
immediately by a high power 900 observing pulse (10). Classical
sequences for COSY and NOESY experiments were used (1 1, 12).
RESULTS AND DISCUSSION
The previous assigments (6, 7) were confirmed by two-
dimensional-COSY and one-dimensional and two-dimen-
sional NOE's experiments at high fields. The chemical
shifts and coupling constants are shown in Table I. The 400
MHz spectra of native and L-Ala2 dermorphins are shown
in Fig. 1. A representative two-dimensional spectrum is
shown in Fig. 2.
Conformational Information from
Chemical Shifts
Ring current shifts were suspected in dermorphin owing to
the presence of three aromatic residues in the sequence.
Indeed, a comparison of the chemical shifts of the alanine
methyl group in the two dermorphins with each other and
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TABLE I
COMPARISON BETWEEN DATA IN
LITERATURE (13) OF MODEL PEPTIDES
CHEMICAL SHIFTS AT 400 MHz OF
DEMORPHIN AND ITS L-Ala2 ANALOGUE*
THE
AND
THE
Tyr Ala Phe Gly Tyr Ser
N-H
Standard 8.04 8.14 8.15 8.04 7.98
D-Epta 8.11 8.38 8.39 8.29 8.31 7.76
L-Epta 7.95 8.58 8.18 8.21 8.58 7.72
CaH
Standard 4.34 4.56 3.76 4.463.76
D-Epta 3.96 4.30 4.56 3.57 4.603.81
L-Epta 3.93 4.36 4.62 360 4.543.76
CpH2
Standard 1.22 2.75 2.643.03 - 2.91
D-Epta 2.86 0.74 2.72 2.65
_3.02 2.97
L-Epta 2.2 1.20 - 712.62 _2.92 3.03 2.92
*The L-Ala2 analogue
located at 2.50 ppm.
refers to the DMSO-d6 resonance arbitrarily
with standard alanine methyl chemical shifts (13) reveals
an upfield shift of the D-Ala2 methyl protons by 0.5 ppm.
The corresponding L-Ala derivative does not exhibit any
relevant shift. Proof that this shift is due to the Phe3 ring
current and to the Tyr' ring current was obtained from
specific NOE between the methyl and aromatic protons.
Further confirmation came from the rather high tempera-
ture coefficient of the D-Ala2-CH3 chemical shift (0.0035
ppm/0C). The downfield shift observed with increasing
temperature indicates that the X rotamers causing the
anomalous shift have higher than average populations.
These data are therefore consistent with the hypothesis
that the D-Ala2 methyl group is located between the two
aromatic rings and with its hydrogens placed <3 A from
each ring (14), thus imposing severe restrictions on the
backbone (0,)) angles and on the x rotamer populations of
residues 1 and 3. A comparative analysis of all chemical
shift data (Table I) of the two dermorphins reveals that,
although the dramatic difference observed for the alanine
methyl groups is a singular data, there are many small but
significant differences that point to the existence of dif-
ferent conformational states in solution for the two com-
pounds. For instance the chemical shift of the D-Ala NH is
shifted by 0.2 ppm with respect to the corresponding L-Ala
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FIGURE 1 'H NMR spectra of dermorphin and its L-Ala2 analogue (top) in DMSO-d6 at 400 MHz.
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FIGURE 2 600 MHz NOESY spectrum of dermorphin (10 mM) at 2980K.
value and by 0.54 ppm with respect to values given in the
literature for random coil conformations. A similar behav-
ior is also exhibited by the 6NH of Phe (3). In view of the
extreme similarity of constitution of the two peptides (the
only difference being in the chirality of the second residue),
any experimental data that may account for their different
biological activity is of potential diagnostic value.
Conformational Information from Scalar
¾! Values
All ¾J!, values reported in Table II fall in the range 7.9 to
8.8 Hz (corresponding to 8.7-9.6 Hz if the correction for
electronegativity is considered). At this stage it is not yet
possible to discriminate between single 4) angles and appro-
priate averages over all accessible 4) angles. At any rate, the
very high values found experimentally automatically
exclude fourfold degeneracies essentially yielding pairs of
likely angles that correspond to a rather narrow range of r,,
distances (averaged or single), i.e., to values comprised
between 2.7 and 3.0 A (15). All possible pairs of 4) values
derived from the Karplus relationship are shown in Table
IL.
Conformational Information from 4) and if1
NOEs
No significant NOEs were detected at 80 MHz but they
became negative and of progressively increasing magni-
tude at 270, 400, 500, and 600 MHz. This implies that the
correlation time in DMSO-d6 at 250C is -1i09 s (16), a
value, as expected, that is intermediate between those
observed, in the same solvent, for the pentapeptide meten-
TABLE II
3JHNCH COUPLING CONSTANTS OF DERMORPHIN
AND THE CORRELATED 0 AND 4' ANGLES*
JHNCH JHNCH 04
Hz Hz
D-Ala 7.9 8.7 1520 920, 1480
Phe 8.8 8.9 1530 ..930, -1470
Gy 5.7 5.9 ±600-
Gy 6.0 6.2 ±128-
Tyr 8.1 9.6 1590 -1410, ..990
Scr 7.9 8.5 1500 -1500, -9o0
90 690, 510
HNITCH are corrected by the electronegativity factor (26).
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kephalin (17) and the decapeptide gramicidin S (18). The
quoted NOEs (17, 18), alone or in combination with
relaxation rates or scalar coupling constants have yielded
accurate proton-proton distances that agreed with dis-
tances derived from diffraction studies (19, 20). Because
we are dealing with a linear peptide where X, A/, and other
motions are more complex than in cyclic peptides, we will
only claim semiquantitation in our calculations. The NOE
ratios and relative notation are shown in Table III. The
ratios are classified according to the following scheme:
R R Hi+2
-N- -C:CO N- + C'-N-
Hi4 Hi+I i+1
SCHEME I
The data set is complete enough to postulate either a single
extended conformation for dermorphin or else a limited set
of closely related conformations. In all cases (a) the 4
NOEs are very small, an observation that entirely supports
the conclusions from scalar couplings that the 4 dihedral
angles of all peptide units are transoid with r, of the order
of 2.7 to 2.9 A; (b) the ,6 NOE is always greater than the 4
TABLE III
PROTON-PROTON NUCLEAR OVERHAUSER
EFFECT MEASUREMENTS AT 500 MHz
Irradiated Observed Actual
proton proton NOE*
Tyr' NH3+ Tyr' C.H2 4
Ala2 CaH 19
D-Ala2 NH and Phe3 Ala2 CH3 2
NH Phe3CaH 5
Tyr' CaH 9
Tyr3CaH 13
Gly4 and Tyr3 NH Gly4 C.H. 4
Gly4C.Hd 5
Ser' NH Ser7 C.H 10Pro'6C,H 12
Ala2NH 22Tyr' C.H Tyr' NH 7
Phe3NH 18
2 ~~~Ala2NH 0D-Ala2 CaH and Pro' Tyr'NH3 4
CaH Ser7 NH 6
Pro6 CpH2 2
Tyr5 C.H and Phe3 Tyr' NH + Gly4 NH 19
C.H Phe3NH + Ala2NH 15
Ser7 CaH Ser NH 4
*The NOE effects were calculated as indicated in reference 27 and are
classified according to Scheme I given in the text.
NOE for every residue, and applying the NOE ratio
method with the assumption r*, is equal to 2.7 to 2.9 A
yielded r/ distances -2.3 A. This figure corresponds to i4
angles that are also transoid. The monoselective relaxation
rates were measured for each proton of the backbone to
ensure that there were no anomalously relaxing protons
(unpublished results). What was particularly encouraging
was that the (4, 0) angles of Table III and hence the
secondary conformation calculated from 3J4 and NOE
parameters readily permitted the close approach of the
Tyr' and Phe3 rings to the D-Ala2 CH3 group. Thus several
types ofNMR parameters, which have a different theoreti-
cal and physical basis readily account for the same confor-
mation. By assuming the existence of a single conformation
rather than a set of related conformations, it is possible to
build a detailed molecular model (Fig. 3). The conforma-
tions of the side chains shown in Fig. 3 were likewise
derived from the analysis of the 3J" coupling constants(vide infra).
Conformational Information from NMR
Studies of Hydrogen Bonds
The now traditional NMR parameters used to elucidate
solvent exposed vs. solvent shielded amide protons in
peptides are shown in Table IV. The proton-deuterium
exchange rates are all of the same order of magnitude,
except that of the NH' group, which exchanges very
rapidly, owing the presence of the charge. Much care has
to be taken to interpret these measurements because little
is known about the effect of DMSO on the amide-water
hydrogen exchange (21, 22). Furthermore, absolute rates
of exchange depend critically on the pH and on the amount
of water present; also the maximum of care must be taken
to exclude traces of metal ions, which can greatly affect
proton exchange rates. Our data seem to indicate that all
amide protons have similar local conformations. The Ab/
AT coefficients are neither very small nor very large and
are again consistent with a similar environment for each.
TABLE IV
TEMPERATURE COEFFICIENTS (O1A/OT) OF THE
AMIDE PROTONS OF DERMORPHIN AND ITS
L-Ala2 ANALOGUE IN THE RANGE 297-3250K AND
PROTON-DEUTERIUM EXCHANGE RATES OF
DERMORPHIN ADDING 2% D20 IN DMSO-d6
L-Epta D-Epta l
Ac/AT AO/AT T'/
ppb/c h
Tyr' -2.3 -2.3 5m
Ala2 -5.7 -5.2 3.0
Phe3 (-7.7) -8.1 3.3
Gly4 (-7.7) (-10) 4.0
Tyr5 -8.8 (-10) 4.2
Ser7 -6.0 -6.2 2.2
Temperature was also varied from 297 to 3250K during the exchange in
order to increase the rates.
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FIGURE 3 One of several conformations for dermorphin that fits all the NMR data. The 4i angles are transoid, the 4 angles are about - 150°
(+ 1500 for D-Ala), and the x angles are consistent with the value of the higher population (trans). o, C; *, N; 0, 0.
The vast majority of model peptides used to establish
relationships between Ab/AT and solvent shielding were
cyclic and contained ,B sheet, : turn, and y turn moieties
(23, 24). An insufficient number of model linear peptides
of defined conformation have been studied. It is therefore
premature at this stage to speculate that this data for
dermorphin can distinguish between the many different
types of helix or extended structures that fit all our data.
What is clear is that it supports a regular structure that is
not random coil. The other NMR data clearly delineate
that the conformation is linear and extended with all X and
4' angles transoid.
Conformational Information from
Side-Chain Populations
The populations of some of the side chains of both D- and
L-Ala dermorphin were calculated by means of the well-
known equations of Pachler (25) and are reported in Table
V. Conformers I, II, and III correspond to conformations
in which the R group of a -CH2R side chain is trans to the
following carbonyl, gauche to the same carbonyl or gauche
TABLE V
FRACTIONAL POPULATIONS OF SIDE CHAINS
FOR SOME RESIDUES OF DERMORPHIN AND ITS
L-Ala2 ANALOGUE
'Tyr 3Phe 5Tyr
Conformer
D-Epta L-Epta D-Epta L-Epta D-Epta L-Epta
I 56.6 68.1 54.0 68.5 56.9
II 24.6 15.2 19.4 14.7 19.4
III 18.8 16.7 26.6 16.8 23.7
The values are calculated according to Pachler (25).
to both the following carbonyl and to the preceding NH,
respectively. The figures for Tyr' of the D-Ala2 peptide are
missing since the ABX system of this side chain yields a
deceptively simple spectrum. Conformer I is always the
most populated one in all residues but note that the
distribution among the three conformers is more uniform
for the side chains of the L-Ala2 analogue, whereas the
distribution for the side chains of the natural peptide is
suggestive of the prevalence of a single conformer. These
data support once again the hypothesis of a smaller
number of global conformations of the D-analogue with
respect to the L.
CONCLUSION
The solution structure of dermorphin has been studied in
great detail with the aid of all possible 'H NMR methods.
Although it may be difficult to describe accurately the
conformation of a linear heptapeptide in solution, this
attempt was justified by several reasons. For instance, the
clear ,u activity of this opioid makes a comparison of its
conformation(s) with the structure of rigid alkaloid opiates
potentially more useful than in the case of enkephalins,
whose selectivity is rather toward the 6 receptor. Most of
all, observation of clear NOE effects at several fields can
substantiate all otherNMR data, whereas in the case of all
linear peptide opioids previously studied these effects were
barely detectable owing to the extreme narrowing limit
condition imposed by the lower molecular weight. The
combined use of conventional NMR parameters and of
NOE effects delineates, for dermorphin in DMSO, an
essentially extended structure that might be the result of
the average among a limited number of structures in a
small portion of conformational space. It is likely that this
kind of global shape of dermorphin in solution be, in part, a
PASTORE ET AL. A Conformational Study of the Opioid Peptide Dermorphin 199
consequence of strong interactions of the NH groups with
DMSO molecules. This doubt was not clarified by the 2H
exchange data and by the temperature dependence of the
NH chemical shifts, but such a situation emphasizes once
more the need for acquiring better reference data, in this
solvent, with model peptides. Nonetheless it is fair to say
that our structural data do give a very accurate description
of local preferences, at least for single residues and for
pairs of adjacent residues. Of particular importance for the
structure-activity relationship is the arrangement of the
first three residues, also considering the fact that the
[L-Ala2] analogue showed clearly different NMR parame-
ters for these residues. In general, the comparative study of
the two dermorphins, i.e., the natural (D-Ala2) one and the
synthetic (L-Ala2) analogue suggests that the role of
(D-Ala2) in directing the conformational preferences of the
natural peptide is central. In fact, all measured NMR
parameters do indicate that the two dermorphins occupy
distinct regions of the conformational space. It is not far
fetching to suppose that it will be possible, in the very near
future, to correlate these differences to the large difference
of analgesic activity.
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